Abstract:Tributyrin (TB) can be hydrolyzed into short chain fatty acids (butyric acid) in the gastrointestinal tract, which are claimed to exhibit beneficial health effects in the colon. However, digestion of tributyrin in the stomach and small intestine may promote its absorption in the upper gastrointestinal tract, thereby reducing its potential colonic health benefits. In this study, we therefore developed a novel method of encapsulating emulsified tributyrin within biopolymer-based hydrogel beads (approximate to 800 mu m) that were then encapsulated inside the boba beads (approximate to 8-10 mm) found in bubble tea. The hydrogel beads were designed to retain and protect the tributyrin under upper gastrointestinal tract (GIT) conditions, but then release it within the colon. The concentration of tributyrin within the boba beads was 33.3 mg/g, which is above the value reported to exhibit health benefits. The morphology, encapsulation properties, water holding capacity, stability, and swelling properties of the tributyrin-loaded boba beads were characterized. Tapioca-based beads exhibited a larger degree of swelling when incubated in water for 12h (>95 %), whereas agar-based beads did not (< 20 %). In addition, the potential gastrointestinal fate of both free and encapsulated tributyrin oil droplets was assessed using an in vitro digestion model. The free tributyrin oil droplets were almost completely hydrolyzed (103.2 %) by the end of the small intestine phase, whereas the tributyrin oil droplets encapsulated within the agar-based (29.4 %) or tapioca-based (40.3 %) boba beads were much more resistant to digestion. The tapioca-based beads were partially broken down as they passed through the simulated GIT, while the agar-based beads maintained their structural integrity. The tapioca-based beads were gradually broken down as they passed through the simulated GIT, while the agar-based ones maintained their structural integrity. Agar beads were also harder, more resilient, and chewier than the tapioca ones. Both types of boba beads tended to swell and disintegrate when heated to high temperatures (90 degrees C), with the effect being more pronounced for the agar beads. Overall, our results suggest that the agar- based boba beads had greater potential for the delivery of tributyrin to the colon than the tapioca-based ones. The recent popularity of bubble tea means that it may be a suitable vehicle for delivering bioactive food components, like functional lipids, vitamins, nutraceuticals, or probiotics.

In Vitro Digestion and Fermentation of Microencapsulated Tributyrin for the Delivery of Butyrate

Encapsulation of tributyrin by gamma-cyclodextrin: Complexation, spray drying, and in vitro fermentation

Preparation and synbiotic interaction mechanism of microcapsules of Bifidobacterium animalis F1-7 and human milk oligosaccharides (HMO)

Microencapsulation of Bacillus Smithii XY1 by Spray Drying and Evaluation for Treatment of Inflammatory Bowel Disease

Encapsulated Tributyrin With Gamma-Cyclodextrin Modulated the Gut Microbiota Composition in a DSS-Challenge Piglet Model

Lacticaseibacillus rhamnosus ATCC 53103 and Limosilactobacillus reuteri ATCC 53608 Synergistically Boost Butyrate Levels upon Tributyrin Administration Ex Vivo

Physicochemical and Functional Characterization of Newly Designed Biopolymeric-Based Encapsulates with Probiotic Culture and Charantin

In-vitro GIT Tolerance of Microencapsulated Bifidobacterium bifidum ATCC 35914 Using Polysaccharide-Protein Matrix

Long-Term Production of Butyric Acid Through Immobilization of Clostridium Tyrobutyricum in Amoving Fibrous-Bed Bioreactor (Mfbb)

Microencapsulation of Lacticaseibacillus rhamnosus GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release

Enhanced Butyric Acid Tolerance And Bioproduction By Clostridium Tyrobutyricum Immobilized In A Fibrous Bed Bioreactor

Protein-polysaccharide based double network microbeads improves stability of Bifidobacterium infantis ATCC 15697 in a gastro-Intestinal Tract Model (TIM-1)

An in vitro gastrointestinal model to evaluate the tolerance of encapsulated Lactobacillus and Lactococcus strains with synbiotic containing lactobionic acid via lyophilization technique to harsh gastric conditions during storage time

Microencapsulation of Bifidobacterium bifidum F-35 in whey protein-based microcapsules by transglutaminase-induced gelation.

Efficient Protection of Probiotics for Delivery to the Intestinal tract by Cellulose Sulphate Encapsulation

Effects of Tributyrin Supplementation on in Vitro Culture Fermentation and Methanogenesis and in Vivo Dietary Nitrogen, Calcium and Phosphorus Losses in Small Tail Ewes

Construction of Biopolymer-Based Hydrogel Beads for Encapsulation, Retention, and Colonic Delivery of Tributyrin: Development of Functional Beverages (fortified Bubble Tea)

Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease Therapy.

Microencapsulation and controlled release of Bacillus clausii through a novel non-digestible carbohydrate formulation as revolutionizing probiotic delivery

Enhanced in Vitro Functionality and Food Application of Lactobacillus Acidophilus Encapsulated in a Whey Protein Isolate and (-)-epigallocatechin-3-gallate Conjugate.

Innovative Insights for Establishing a Synbiotic Relationship with Bacillus coagulans: Viability, Bioactivity, and In Vitro-Simulated Gastrointestinal Digestion